Godavari Drugs Ltd vs Rpg Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of Godavari Drugs Ltd is ₹ 130 as of 08 May 16:01 . The P/E Ratio of Godavari Drugs Ltd changed from 8.4 on March 2021 to 15 on March 2025 . This represents a CAGR of 12.30% over 5 yearsThe P/E Ratio of RPG Life Sciences Ltd changed from 16 on March 2021 to 20.6 on March 2025 . This represents a CAGR of 5.18% over 5 years The Market Cap of Godavari Drugs Ltd changed from ₹ 34.45 crore on March 2021 to ₹ 65.86 crore on March 2025 . This represents a CAGR of 13.84% over 5 yearsThe Market Cap of RPG Life Sciences Ltd changed from ₹ 640.23 crore on March 2021 to ₹ 3766 crore on March 2025 . This represents a CAGR of 42.54% over 5 years The revenue of Godavari Drugs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of RPG Life Sciences Ltd for the Mar '26 is ₹ 190.39 crore as compare to the Dec '25 revenue of ₹ 183.44 crore. This represent the growth of 3.79% The ebitda of Godavari Drugs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of RPG Life Sciences Ltd for the Mar '26 is ₹ 46.33 crore as compare to the Dec '25 ebitda of ₹ 34.75 crore. This represent the growth of 33.32% The net profit of Godavari Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The net profit of RPG Life Sciences Ltd changed from ₹ 34.93 crore to ₹ 29.9 crore over 6 quarters. This represents a CAGR of -9.85% The Dividend Payout of Godavari Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of RPG Life Sciences Ltd changed from 29.77 % on March 2021 to 21.66 % on March 2025 . This represents a CAGR of -6.16% over 5 years .

About Godavari Drugs Ltd

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates and fine chemicals catering to global life science industry.
It works a manufacturing plant at Nanded, Maharashtra, India.
Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand.
Company apart from its own products, explores continual opportunities for loan licence manufacturing with reputed multinational companies. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.

About RPG Life Sciences Ltd

RPG Life Sciences Limited, formerly known as Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group.
The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited'.
During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007.
On February 13, 2008, the name of the Company was changed to RPG Life Sciences Limited. During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes.

FAQs for the comparison of Godavari Drugs Ltd and RPG Life Sciences Ltd

Which company has a larger market capitalization, Godavari Drugs Ltd or RPG Life Sciences Ltd?

Market cap of Godavari Drugs Ltd is 127 Cr while Market cap of RPG Life Sciences Ltd is 4,103 Cr

What are the key factors driving the stock performance of Godavari Drugs Ltd and RPG Life Sciences Ltd?

The stock performance of Godavari Drugs Ltd and RPG Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Godavari Drugs Ltd and RPG Life Sciences Ltd?

As of May 8, 2026, the Godavari Drugs Ltd stock price is INR ₹126.1. On the other hand, RPG Life Sciences Ltd stock price is INR ₹2480.95.

How do dividend payouts of Godavari Drugs Ltd and RPG Life Sciences Ltd compare?

To compare the dividend payouts of Godavari Drugs Ltd and RPG Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.